Corporate Information And Statement Of Ifrs Compliance [Abstract]
| Concept |
2023-01-01 to 2023-12-31 |
|---|---|
| Corporate information and statement of IFRS compliance [abstract] | |
| Domicile of entity |
Belgique
|
| Legal form of entity |
société anonyme
|
| Address of entity's registered office |
Boulevard Patience et Beaujonc
|
| Description of nature of entity's operations and principal activities |
Hyloris est une société biopharmaceutique
|
| Name of parent entity |
Hyloris Pharmaceuticals SA
|
| Name of ultimate parent of group |
Hyloris
|
| Statement of IFRS compliance [text block] |
Les états financiers consolidés du Groupe pour
|
| Disclosure of reclassifications or changes in presentation [text block] |
31. RETRAITEMENT DES ÉTATS 2022
|
| Disclosure of material accounting policy information [text block] |
2. RÉSUMÉ DES PRINCIPALES MÉTHODES
|
| Disclosure of objectives, policies and processes for managing capital [text block] |
14
|